HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eva Vidacs Selected Research

Cytostatic Agents

1/2017HDAC Inhibitor Panobinostat Engages Host Innate Immune Defenses to Promote the Tumoricidal Effects of Trastuzumab in HER2+ Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eva Vidacs Research Topics

Disease

6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 01/2015
5Leukemia
01/2022 - 01/2015
4Neoplasms (Cancer)
01/2017 - 11/2013
3Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 11/2013
1Inflammation (Inflammations)
10/2020
1Lymphoma (Lymphomas)
11/2015
1Sarcoma (Soft Tissue Sarcoma)
10/2013

Drug/Important Bio-Agent (IBA)

5PanobinostatIBA
01/2022 - 01/2015
4Histone Deacetylase InhibitorsIBA
01/2022 - 01/2015
3Proteins (Proteins, Gene)FDA Link
11/2016 - 01/2015
2Arsenic Trioxide (Trisenox)FDA Link
11/2020 - 01/2015
1EnzymesIBA
01/2022
1ivosidenibIBA
01/2022
1alpha-hydroxyglutarateIBA
01/2022
1pyrimidineIBA
01/2022
1Interferon Type IIBA
01/2022
1Interleukin-8 (Interleukin 8)IBA
10/2020
1Cytostatic AgentsIBA
01/2017
1Trastuzumab (Herceptin)FDA Link
01/2017
1dinaciclibIBA
03/2016
1RGFP966IBA
11/2015
1VorinostatFDA Link
11/2015
1romidepsin (FK228)FDA Link
11/2015
1belinostatIBA
11/2015
1CaspasesIBA
11/2015
1Histone Deacetylases (Histone Deacetylase)IBA
11/2015
1ABT-737IBA
11/2013
1MethylcholanthreneIBA
10/2013
1CarcinogensIBA
10/2013

Therapy/Procedure

2Therapeutics
01/2017 - 11/2013